Simon N - Search Results

1

Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.

Simon N, Dussol B, Sampol E, Purgus R, Brunet P, Lacarelle B, Berland Y, Bruguerolle B, Urien S. Simon N, et al. Clin Pharmacokinet. 2006;45(5):493-501. doi: 10.2165/00003088-200645050-00004. Clin Pharmacokinet. 2006. PMID: 16640454 Clinical Trial.

2

Population pharmacokinetics analysis of mycophenolic acid in adult kidney transplant patients with chronic graft dysfunction.

Guillet BA, Simon NS, Purgus R, Botta C, Morange S, Berland Y, Pisano PS. Guillet BA, et al. Ther Drug Monit. 2010 Aug;32(4):427-32. doi: 10.1097/FTD.0b013e3181e6b54d. Ther Drug Monit. 2010. PMID: 20592648

3

Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.

Simon N, Sampol E, Albanese J, Martin C, Arvis P, Urien S, Lacarelle B, Bruguerolle B. Simon N, et al. Clin Pharmacol Ther. 2003 Oct;74(4):353-63. doi: 10.1016/S0009-9236(03)00201-7. Clin Pharmacol Ther. 2003. PMID: 14534522 Clinical Trial.

4

Vancomycin: a review of population pharmacokinetic analyses.

Marsot A, Boulamery A, Bruguerolle B, Simon N. Marsot A, et al. Among authors: simon n. Clin Pharmacokinet. 2012 Jan 1;51(1):1-13. doi: 10.2165/11596390-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22149255 Review.

5

Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.

Bruguerolle B, Simon N. Bruguerolle B, et al. Among authors: simon n. Clin Neuropharmacol. 2002 Jul-Aug;25(4):194-201. doi: 10.1097/00002826-200207000-00002. Clin Neuropharmacol. 2002. PMID: 12151906 Review.

6

Biological rhythms: a neglected factor of variability in pharmacokinetic studies.

Bruguerolle B, Boulamery A, Simon N. Bruguerolle B, et al. Among authors: simon n. J Pharm Sci. 2008 Mar;97(3):1099-108. doi: 10.1002/jps.21044. J Pharm Sci. 2008. PMID: 17705158 Review.

7

Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves.

Semmar N, Urien S, Bruguerolle B, Simon N. Semmar N, et al. Among authors: simon n. J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):159-83. doi: 10.1007/s10928-007-9082-0. Epub 2008 Feb 22. J Pharmacokinet Pharmacodyn. 2008. PMID: 18293065

8

Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.

Brunet P, Simon N, Opris A, Faure V, Lorec-Penet AM, Portugal H, Dussol B, Berland Y. Brunet P, et al. Among authors: simon n. Am J Kidney Dis. 2008 May;51(5):789-95. doi: 10.1053/j.ajkd.2007.12.040. Am J Kidney Dis. 2008. PMID: 18436089

9

Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.

Solas C, Gagnieu MC, Ravaux I, Drogoul MP, Lafeuillade A, Mokhtari S, Lacarelle B, Simon N. Solas C, et al. Among authors: simon n. Ther Drug Monit. 2008 Dec;30(6):670-3. doi: 10.1097/FTD.0b013e3181897bff. Ther Drug Monit. 2008. PMID: 18806695

10

Population pharmacokinetic analysis during the first 2 years of life: an overview.

Marsot A, Boulamery A, Bruguerolle B, Simon N. Marsot A, et al. Among authors: simon n. Clin Pharmacokinet. 2012 Dec;51(12):787-98. doi: 10.1007/s40262-012-0015-8. Clin Pharmacokinet. 2012. PMID: 23179579 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,538 results

Search Page

Filters